The Aduco office will be closed on November 28–29 for Thanksgiving.

The Aduco office will be closed on December 24–25 for Christmas. Any orders placed during this time will be shipped on the next business day.

BioPro 30 DF

SKU: 1135
BioPro 100 DF provides four researched strains of beneficial bacteria totaling 30 billion CFU per capsule, including the extensively studied HN019® strain of Bifidobacterium lactis.
  • Helps Maintain a Healthy Intestinal Microecology*
  • Supports the Natural Immune Response*
  • Supports Bowel Regularity*
  • Supports Lactose Digestion*

Vegetarian  |  Dairy-Free  |  Gluten-Free

Shipping calculated at checkout.
Login to Purchase

    • Discover BioPro 30 DF, a vegetarian probiotic with 30 billion CFU per capsule. This dairy-free, gluten-free formula features four beneficial bacterial strains:

      • HOWARU® (Bifidobacterium lactis HN019®)
      • Lactobacillus acidophilus (Lactobacillus acidophilus La-14)
      • Lactobacillus plantarum (Lactobacillus plantarum Lp-115)
      • Bifidobacterium longum (Bifidobacterium longum Bl-05)

      To further support resistance to low pH and the delivery of microorganisms to the small intestines, Focal Evolve employs DRcapsTM gastro-resistant capsules. These specially designed, innovative capsules help slow exposure of actives to stomach acid and ensure more targeted release.* Each vegetarian capsule is sealed in nitrogen-purged aluminum blister packs to serve as protection from factors proven to compromise the stability of probiotics such as heat, moisture, and oxygen.

      BioPro 30 DF Benefits:

      • supporting metabolic activity, such as the production of short-chain fatty acids and vitamins, nutrient absorption, and digestion of lactose
      • adhering to intestinal epithelial cells to help maintain a healthy balance of organisms in the intestinal tract
      • helping to establish populations of good bacteria after disruption in balance
      • supporting immune function
      • promoting intestinal epithelial cell survival
      • supporting healthy bowel function degrading oxalates.*

      Download BioPro 30 DF product detail sheet here

    Discover BioPro 30 DF, a vegetarian probiotic with 30 billion CFU per capsule. This dairy-free, gluten-free formula features four beneficial bacterial strains:

    • HOWARU® (Bifidobacterium lactis HN019®)
    • Lactobacillus acidophilus (Lactobacillus acidophilus La-14)
    • Lactobacillus plantarum (Lactobacillus plantarum Lp-115)
    • Bifidobacterium longum (Bifidobacterium longum Bl-05)

    To further support resistance to low pH and the delivery of microorganisms to the small intestines, Focal Evolve employs DRcapsTM gastro-resistant capsules. These specially designed, innovative capsules help slow exposure of actives to stomach acid and ensure more targeted release.* Each vegetarian capsule is sealed in nitrogen-purged aluminum blister packs to serve as protection from factors proven to compromise the stability of probiotics such as heat, moisture, and oxygen.

    BioPro 30 DF Benefits:

    • supporting metabolic activity, such as the production of short-chain fatty acids and vitamins, nutrient absorption, and digestion of lactose
    • adhering to intestinal epithelial cells to help maintain a healthy balance of organisms in the intestinal tract
    • helping to establish populations of good bacteria after disruption in balance
    • supporting immune function
    • promoting intestinal epithelial cell survival
    • supporting healthy bowel function degrading oxalates.*

    Download BioPro 30 DF product detail sheet here

    About Focal Evolve

    Focal Evolve provides a comprehensive selection of dietary supplement formulas across diverse wellness categories, including detox, gastrointestinal support, bone health, brain support, and immune health. High quality clinical research drives the purpose behind the Focal Evolve brand. Focal Evolve supplements prove highly effective when designing protocols for patients with exceptionally specific food sensitivities or complex nutritional demands stemming from advanced disease states.
    {